JGA Chief Wary of “Full” Off-Year Revision in 2025, Urges Broader Exemptions If Plan Goes Forward

January 25, 2024
New JGA President Hiroki Takada The Japan Generic Medicines Association (JGA) certainly opposes the “full implementation” of the next “off-year” drug price revision in FY2025, but it is also preparing proposals that would be more palatable to financial authorities in...read more